Key End Points in Clinical Trials

Pharmacy Times October 11, 2024
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, Amir Ali, PharmD, BCOP, Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, Amir Ali, PharmD, BCOP, Brooke Adams, PharmD, BCOP

Key Takeaways

• Progression-free survival and overall survival are key endpoints in multiple myeloma trials, crucial for evaluating treatment efficacy.
• Stringent eligibility criteria in clinical trials may limit their applicability to real-world scenarios, necessitating more inclusive designs.
• Incorporating diverse patient populations, including those with comorbidities, can enhance the relevance of trial outcomes.
• Real-world endpoints such as quality of...

Today's Sponsors

Today's Sponsor